Navigation Links
Johnson & Johnson Announces $1.75 Million Donation to Save the Children to Support Syrian Humanitarian Refugee Crisis

NEW BRUNSWICK, N.J., Nov. 17, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced an expanded partnership with Save the Children to support children impacted by the Syrian refugee crisis and strengthen long-term resiliency in their communities. The $1.75 million commitment was announced in advance of Save the Children's third annual Illumination Gala in New York City.

"The distressing images of families caught in the global refugee crisis highlight the importance of our ongoing commitment to Save the Children," said Alex Gorsky, Chairman and CEO of Johnson & Johnson. "We believe the mission of our Company to help people everywhere live longer, healthier and happier lives must begin with families in need, so we are proud to partner in this effort."

Funding from Johnson & Johnson will be used to address immediate humanitarian needs, including access to food and clean water, safe shelter, hygiene resources and winter clothing. The funding will also support the sustainable long-term recovery of impacted communities. Central to this are resilience-building activities, which include educational programing, mental health support and community-building initiatives for the displaced families.

Joaquin Duato, Worldwide Chairman, Pharmaceuticals, Johnson & Johnson and member of the Save the Children Board of Trustees, who will speak at the Illumination Gala, said, "At Johnson & Johnson, we believe companies should stand together with their communities in times of greatest need. We are fortunate to have strong partners like Save the Children to respond to the immediate challenges in Syria as well as creating a sustainable and brighter future for those touched by this crisis."

According to the United Nations, over 12 million people are in need of humanitarian support inside Syria, including 5.6 million children. Additionally, more than 4 million people, mostly women and children, have fled the often unsafe refugee camp environments to find asylum in Europe and face dangers such as drowning or violence on their journey. Children are especially vulnerable in the camps and along the transit routes, often arriving alone, leaving them at risk of trafficking, abuse and exploitation.

"We are now seeing the greatest wave of refugees migrating across Europe since World War II - many of them young children," said Carolyn Miles, President and CEO of Save the Children. "With the support of generous partners like Johnson & Johnson, our response teams in Greece, Italy, Serbia and Germany have been able to provide urgently needed supplies and shelter for parents seeking a better life for their families.  Johnson & Johnson's $1.75 million donation will provide for the immediate needs of thousands of children on the run, as well as recovery programs that can help them find hope again."

Today's commitment will expand on the previous investments from the Johnson & Johnson Family of Companies in Europe and the Middle East, as well as the Johnson & Johnson Corporate Citizenship Trust. Over the last several years Johnson & Johnson has been involved in multiple health interventions in supporting the plight of Syrian refugees. This work has included training pediatricians caring for refugees; donations of blankets, hygiene products and trauma equipment; as well as activating employee volunteers.

Last year, Johnson & Johnson announced a $10 million, multi-year commitment to support Save the Children's core mission, program support to improve newborn survival, local activation and gift-in-kind services. In addition, Johnson & Johnson is the presenting sponsor of tonight's Save the Children Illumination Gala and continues to support Save the Children in non-monetary ways, including advocacy and thought leadership, media awareness building, and employee engagement.

About Johnson & Johnson
Caring for the world one person at a time inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 128,000 employees at more than 265 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

About the Janssen Pharmaceutical Companies of Johnson & Johnson
At Janssen, we are dedicated to addressing and solving some of the most important unmet medical needs of our time in infectious diseases and vaccines, oncology, immunology, neuroscience, and cardiovascular and metabolic diseases. Driven by our commitment to patients, we develop innovative products, services and health care solutions to help people throughout the world.

SOURCE Johnson & Johnson
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Johnson & Johnson Announces Agreement To Acquire Novira Therapeutics, Inc.
2. Johnson & Johnson Announces Start of Clinical Trial of Ebola Vaccine Regimen in Sierra Leone
3. Johnson & Johnson Announces Completion of Cordis Divestiture to Cardinal Health
4. UbiVac Announces Collaboration with Johnson & Johnson Innovation to Develop and Test, in Preclinical Studies, a Vaccine to Intercept Oral Cancer
5. Johnson & Johnsons Ethicon Wants Transvaginal Mesh $1.2MM Verdict Thrown Out, says Legal-Bay Lawsuit Settlement Funding
6. Johnson & Johnson Innovation Announces Collaboration on Immuno-Oncology Antibody ADC-1013 with Alligator Bioscience
7. Global Endoscopy Devices Market 2015-2019 - Key Players are Boston Scientific, Johnson and Johnson, Medtronic, Karl Storz & Olympus
8. Arcturus Therapeutics Announces Strategic Collaboration with Johnson & Johnson Innovation to Discover and Develop RNA Medicines for Defined Indications
9. PDA Announces Support for the Johnson & Johnson Kilmer Conference
10. Johnson & Johnson Pharmaceutical Segment to Continue Driving Above-Industry Growth with Plans to File More than 10 New Products by 2019, Each with Potential to Exceed $1 Billion in Revenue
11. Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines
Post Your Comments:
(Date:1/8/2020)... ... January 08, 2020 , ... ... Institute of Silicon Valley, has this week announced the latest medical breakthrough for ... Molybdenum-Rhenium rod in a patient. , The newly FDA cleared MiRus Europa™ Pedicle ...
(Date:1/8/2020)... ... January 09, 2020 , ... R3 ... practices a complimentary freezer program. The cryogenic freezer allows practices to have plenty ... stem cell and exosome biologics require cryogenic freezing. This may include a practice ...
(Date:1/7/2020)... ... 2020 , ... , a comprehensive resource for ... Care Facilities in Fargo, North Dakota. The guide identifies 2 memory care communities ... to the Alzheimer’s Association , 5.6 million people age 65 and older ...
Breaking Medicine Technology:
(Date:1/8/2020)... ... January 09, 2020 , ... ... FDAnews/CenterWatch Webinar, Thursday, Jan. 23, 2020 • 1:30-3:00 p.m. EST, ... data (RWD) to generate evidence and identify gaps and challenges when conducting trials? ...
(Date:1/7/2020)... Ohio (PRWEB) , ... January 07, 2020 , ... ... veterinary equipment, technology and services, today identified six trends that will significantly impact ... occur. , “Arguably, the time shared between a provider and patient is ...
(Date:1/7/2020)... ... 2020 , ... Twenty-six people, all but one who live with Young Onset ... YOPD attend the 6th World Parkinson Congress. The participants, representing 11 countries , ... all 52 weeks in 2020. The group aims to raise at least $50,000 for ...
(Date:1/7/2020)... ... January 06, 2020 , ... A December 6 article ... surgery and fewer complications including high blood pressure and premature birth before or during ... first and their second pregnancies were less likely to suffer adverse pregnancy outcomes the ...
(Date:1/5/2020)... ... January 04, 2020 , ... NJ Top Dentist, Dr. Irvin B. ... specializes in treatment for infants, children, teens and the special needs patient. The practice ... infant nursing and oral health. , Dr. Sherman and his practice will be addressing ...
Breaking Medicine News(10 mins):